4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001437749-22-019667
Pres. Diagnostics & Genom gave up 1,214 shares (to pay taxes)
- Pres. Diagnostics & Genom acquired 2,363 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelderman Kim Pres. Diagnostics & Genom | 2022-08-07 | Option exercise | +2,363 | 4,352 | D | ||
| Kelderman Kim Pres. Diagnostics & Genom | 2022-08-07 | Shares withheld for taxes | −1,214 | $382.97 | $464,926 | 3,138 | D |
| Derivatives | |||||||
| Kelderman Kim Pres. Diagnostics & Genom | 2022-08-07 | Option exercise · Restricted Stock Units | −2,363 | 0 | D | ||
Loading xslF345X03/rdgdoc.xml…